MedTrace Logo

Rectal Misoprostol in Women Undergoing Total Abdominal Hysterectomy for Intraoperative Blood Loss Reduction

NCT05862428 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2023-05-17

No results posted yet for this study

Summary

Comparing of the intraoperative blood loss between group rectal misoprostol group and control group

Conditions

  • Intraoperative Blood Loss

Interventions

DRUG

Rectal misoprostol

This intervention group receive Misoprostol transrectally before undergoing total abdominal hysterectomy

Sponsors & Collaborators

  • Queen Savang Vadhana Memorial Hospital, Thailand

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-18
Primary Completion
2022-09-26
Completion
2022-09-26

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862428 on ClinicalTrials.gov